Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/3140

TDMS Study 05007-05 Pathology Tables



                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                           POLYSORBATE 80


NTP Experiment-Test: 05007-05                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/03/94
Route: DOSED FEED                                                                                                 Time: 11:32:39




       Facility:  Southern Research Institute

       Chemical CAS #:  9005-65-6

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                  9           10           10                                                  
  Early Deaths                                                                                                                      
    Dead                                              13           15           15                                                  
    Moribund                                           8            7            9                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                30           28           26                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (46)         (18)         (47)                                                
      Infiltration Cellular, Lymphocyte               20 (43%)      2 (11%)     17 (36%)                                            
   Intestine Large, Cecum                             (48)         (18)         (44)                                                
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Intestine Small, Duodenum                          (48)         (19)         (47)                                                
      Serosa, Inflammation, Chronic Active             1 (2%)                                                                       
   Intestine Small, Ileum                             (47)         (18)         (45)                                                
      Serosa, Inflammation, Chronic Active             1 (2%)                                                                       
   Intestine Small, Jejunum                           (48)         (19)         (47)                                                
      Serosa, Inflammation, Chronic Active             1 (2%)                                                                       
   Liver                                              (50)         (25)         (49)                                                
      Cytomegaly                                                                 1 (2%)                                             
      Fatty Change                                     2 (4%)                                                                       
      Focal Cellular Change                            1 (2%)                    1 (2%)                                             
      Hematopoietic Cell Proliferation                20 (40%)      6 (24%)     21 (43%)                                            
      Infiltration Cellular, Lymphocyte               23 (46%)      4 (16%)     23 (47%)                                            
      Inflammation, Acute                              3 (6%)       1 (4%)       5 (10%)                                            
      Necrosis                                         2 (4%)       3 (12%)      2 (4%)                                             
      Vacuolization Cytoplasmic                        2 (4%)                                                                       
      Hepatocyte, Hyperplasia                          1 (2%)                                                                       
      Serosa, Inflammation, Acute                                                1 (2%)                                             
      Serosa, Inflammation, Chronic                    1 (2%)                                                                       
   Mesentery                                          (10)         (5)          (13)                                                
      Cyst                                                          1 (20%)                                                         
      Inflammation, Acute                              4 (40%)      3 (60%)      8 (62%)                                            
      Inflammation, Chronic Active                     2 (20%)                   1 (8%)                                             
      Fat, Necrosis                                    2 (20%)                                                                      
   Pancreas                                           (47)         (22)         (48)                                                
      Abscess                                          1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte               21 (45%)      1 (5%)      15 (31%)                                            
      Inflammation, Acute                                                        2 (4%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic Active                     1 (2%)       1 (5%)       1 (2%)                                             
      Acinus, Atrophy                                  2 (4%)       1 (5%)                                                          
      Duct, Cyst                                                                 2 (4%)                                             
      Duct, Ectasia                                    2 (4%)                                                                       
   Salivary Glands                                    (46)         (18)         (46)                                                
      Infiltration Cellular, Lymphocyte               40 (87%)     12 (67%)     31 (67%)                                            
      Acinus, Atrophy                                                            1 (2%)                                             
   Stomach, Forestomach                               (49)         (50)         (49)                                                
      Cyst Epithelial Inclusion                                     1 (2%)                                                          
      Erosion                                                       1 (2%)       1 (2%)                                             
      Hyperplasia, Squamous                            4 (8%)       8 (16%)     26 (53%)                                            
      Infiltration Cellular, Lymphocyte                1 (2%)                    6 (12%)                                            
      Inflammation, Acute                              2 (4%)       4 (8%)       3 (6%)                                             
      Inflammation, Chronic Active                     2 (4%)                   13 (27%)                                            
      Inflammation, Subacute                                                     1 (2%)                                             
      Mineralization                                   2 (4%)                                                                       
      Ulcer                                            1 (2%)                    7 (14%)                                            
   Stomach, Glandular                                 (49)         (49)         (48)                                                
      Infiltration Cellular, Lymphocyte               15 (31%)      9 (18%)     13 (27%)                                            
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                    3 (6%)                                             
      Mineralization                                   3 (6%)       2 (4%)                                                          
      Mucosa, Ectasia                                  1 (2%)                                                                       
      Mucosa, Inflammation, Acute                                                1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (49)         (22)         (50)                                                
      Embolus Bacterial                                                          1 (2%)                                             
      Infiltration Cellular, Lymphocyte                9 (18%)      3 (14%)      8 (16%)                                            
      Inflammation, Acute                              3 (6%)                    3 (6%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Epicardium, Inflammation, Acute                                            2 (4%)                                             
      Ventricle, Thrombosis                            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland                                      (50)         (22)         (50)                                                
      Capsule, Inflammation, Acute                                               1 (2%)                                             
      Capsule, Inflammation, Chronic Active            1 (2%)                                                                       
   Adrenal Gland, Cortex                              (50)         (22)         (50)                                                
      Congestion                                       1 (2%)                    2 (4%)                                             
      Cyst                                             1 (2%)                                                                       
      Degeneration, Fatty                              3 (6%)                    4 (8%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia                                      2 (4%)                                                                       
      Inflammation, Acute                              2 (4%)                    1 (2%)                                             
      Pigmentation                                    35 (70%)      5 (23%)     32 (64%)                                            
      Spindle Cell, Hyperplasia                       50 (100%)    22 (100%)    49 (98%)                                            
   Adrenal Gland, Medulla                             (50)         (22)         (50)                                                
      Hyperplasia                                      2 (4%)                    2 (4%)                                             
   Islets, Pancreatic                                 (47)         (21)         (48)                                                
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Inflammation, Chronic                                                      1 (2%)                                             
   Parathyroid Gland                                  (26)         (9)          (27)                                                
      Infiltration Cellular, Lymphocyte                1 (4%)                                                                       
   Pituitary Gland                                    (46)         (20)         (48)                                                
      Congestion                                       1 (2%)                                                                       
      Pars Distalis, Angiectasis                       1 (2%)       2 (10%)                                                         
      Pars Distalis, Cyst                              4 (9%)                    1 (2%)                                             
      Pars Distalis, Hyperplasia                       8 (17%)      3 (15%)      8 (17%)                                            
   Thyroid Gland                                      (49)         (19)         (46)                                                
      Infiltration Cellular, Lymphocyte                8 (16%)                   5 (11%)                                            
      Inflammation, Chronic                                                      1 (2%)                                             
      Follicle, Ectasia                                8 (16%)      2 (11%)      5 (11%)                                            
      Follicle, Hyperplasia                            3 (6%)       1 (5%)       2 (4%)                                             
      Follicular Cell, Ectasia                         2 (4%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (48)         (36)         (50)                                                
      Abscess                                          9 (19%)     13 (36%)     16 (32%)                                            
      Angiectasis                                      1 (2%)                                                                       
      Hemorrhage                                       2 (4%)                    1 (2%)                                             
      Mineralization                                   1 (2%)                    1 (2%)                                             
      Follicle, Cyst                                   3 (6%)       1 (3%)       3 (6%)                                             
      Periovarian Tissue, Cyst                         5 (10%)     13 (36%)      8 (16%)                                            
   Uterus                                             (50)         (42)         (50)                                                
      Abscess                                          2 (4%)       3 (7%)       1 (2%)                                             
      Angiectasis                                      1 (2%)                    1 (2%)                                             
      Hydrometra                                       1 (2%)       1 (2%)       1 (2%)                                             
      Endometrium, Abscess                                                       1 (2%)                                             
      Endometrium, Angiectasis                                      1 (2%)                                                          
      Endometrium, Hyperplasia, Cystic                44 (88%)     37 (88%)     45 (90%)                                            
      Endometrium, Inflammation, Acute                 9 (18%)     10 (24%)     17 (34%)                                            
      Endometrium, Metaplasia, Squamous                1 (2%)       1 (2%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (22)         (50)                                                
      Angiectasis                                      1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Myelofibrosis                                   21 (42%)      1 (5%)      13 (26%)                                            
      Myeloid Cell, Hyperplasia                       34 (68%)     14 (64%)     38 (76%)                                            
   Lymph Node                                         (49)         (26)         (49)                                                
      Iliac, Hyperplasia, Lymphoid                     2 (4%)       1 (4%)                                                          
      Mediastinal, Hyperplasia, Lymphoid               3 (6%)       5 (19%)      6 (12%)                                            
      Mediastinal, Inflammation, Acute                              1 (4%)       2 (4%)                                             
      Pancreatic, Hyperplasia, Lymphoid                             1 (4%)                                                          
      Renal, Hyperplasia, Lymphoid                     2 (4%)       6 (23%)      6 (12%)                                            
      Renal, Inflammation, Acute                       1 (2%)       2 (8%)       1 (2%)                                             
   Lymph Node, Mandibular                             (46)         (16)         (46)                                                
      Congestion                                                                 1 (2%)                                             
      Hyperplasia, Lymphoid                           39 (85%)      9 (56%)     39 (85%)                                            
      Inflammation, Acute                                                        1 (2%)                                             
      Pigmentation                                    24 (52%)      1 (6%)      22 (48%)                                            
   Lymph Node, Mesenteric                             (48)         (23)         (48)                                                
      Angiectasis                                      1 (2%)                                                                       
      Congestion                                       4 (8%)       2 (9%)       1 (2%)                                             
      Hyperplasia, Lymphoid                           24 (50%)      9 (39%)     32 (67%)                                            
      Inflammation, Acute                              4 (8%)                    3 (6%)                                             
      Pigmentation                                     1 (2%)                    1 (2%)                                             
   Spleen                                             (49)         (25)         (49)                                                
      Hematopoietic Cell Proliferation                46 (94%)     18 (72%)     44 (90%)                                            
      Hyperplasia, Lymphoid                           19 (39%)      5 (20%)     11 (22%)                                            
      Inflammation, Acute                              4 (8%)       1 (4%)       3 (6%)                                             
      Pigmentation                                    28 (57%)      4 (16%)     26 (53%)                                            
      Capsule, Inflammation, Chronic                   1 (2%)       1 (4%)                                                          
   Thymus                                             (48)         (20)         (48)                                                
      Cyst                                             6 (13%)                   7 (15%)                                            
      Edema                                            1 (2%)                                                                       
      Hyperplasia, Lymphoid                           18 (38%)      6 (30%)     12 (25%)                                            
      Inflammation, Acute                              2 (4%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (49)         (19)         (48)                                                
      Acinus, Ectasia                                  9 (18%)      1 (5%)      13 (27%)                                            
      Duct, Ectasia                                    1 (2%)       5 (26%)      4 (8%)                                             
   Skin                                               (50)         (38)         (50)                                                
      Inflammation, Chronic                           18 (36%)      6 (16%)     15 (30%)                                            
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Inflammation, Multifocal                         1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Head, Ulcer                                                   1 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (22)         (50)                                                
      Cranium, Inflammation, Chronic                                             2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (22)         (50)                                                
      Compression                                                                1 (2%)                                             
      Gliosis                                                                    1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Hydrocephalus                                                 1 (5%)       1 (2%)                                             
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Mineralization                                  26 (52%)      9 (41%)     27 (54%)                                            
      Meninges, Hemorrhage                                                       1 (2%)                                             
      Meninges, Inflammation, Chronic                                            1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (22)         (50)                                                
      Abscess                                          1 (2%)                                                                       
      Congestion                                       2 (4%)       4 (18%)      4 (8%)                                             
      Hemorrhage                                       2 (4%)       1 (5%)       3 (6%)                                             
      Infiltration Cellular, Lymphocyte               48 (96%)     18 (82%)     42 (84%)                                            
      Alveolar Epithelium, Hyperplasia                 2 (4%)                    1 (2%)                                             
      Alveolus, Infiltration Cellular, Histiocyte      4 (8%)       2 (9%)       2 (4%)                                             
      Arteriole, Inflammation, Chronic Active          1 (2%)                                                                       
      Bronchiole, Inflammation, Acute                                            1 (2%)                                             
      Interstitium, Inflammation, Acute                2 (4%)       2 (9%)       5 (10%)                                            
      Interstitium, Inflammation, Chronic                                        1 (2%)                                             
      Interstitium, Inflammation, Chronic Active                                 1 (2%)                                             
      Mediastinum, Atypia Cellular                     1 (2%)                                                                       
      Mediastinum, Inflammation, Acute                 1 (2%)       1 (5%)       3 (6%)                                             
      Peribronchial, Inflammation, Acute                            1 (5%)       1 (2%)                                             
      Pleura, Inflammation, Acute                                   1 (5%)       1 (2%)                                             
   Nose                                               (49)         (22)         (50)                                                
      Lumen, Hemorrhage                               20 (41%)      5 (23%)     13 (26%)                                            
      Mucosa, Inflammation, Acute                      1 (2%)                                                                       
      Nasolacrimal Duct, Hemorrhage                    7 (14%)      1 (5%)      11 (22%)                                            
      Nasolacrimal Duct, Inflammation, Acute                                     1 (2%)                                             
      Olfactory Epithelium, Degeneration              48 (98%)     19 (86%)     49 (98%)                                            
      Respiratory Epithelium, Degeneration             2 (4%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (23)         (50)                                                
      Amyloid Deposition                                            1 (4%)                                                          
      Infiltration Cellular, Lymphocyte               43 (86%)     14 (61%)     40 (80%)                                            
      Inflammation, Acute                              1 (2%)       2 (9%)       2 (4%)                                             
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Chronic Active                     1 (2%)       1 (4%)                                                          
      Metaplasia, Osseous                              3 (6%)                    1 (2%)                                             
      Mineralization                                                             1 (2%)                                             
      Capsule, Inflammation, Chronic Active            1 (2%)                                                                       
      Renal Tubule, Casts Protein                     12 (24%)      1 (4%)      11 (22%)                                            
      Renal Tubule, Ectasia                           20 (40%)      2 (9%)      15 (30%)                                            
      Renal Tubule, Mineralization                     2 (4%)       1 (4%)                                                          
      Renal Tubule, Necrosis                          16 (32%)                  11 (22%)                                            
      Renal Tubule, Regeneration                      15 (30%)                  11 (22%)                                            
   Urinary Bladder                                    (49)         (18)         (48)                                                
      Infiltration Cellular, Lymphocyte               32 (65%)     11 (61%)     35 (73%)                                            
      Inflammation, Acute                              1 (2%)                                                                       
      Serosa, Inflammation, Chronic Active             1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                  7            7           10                                                  
  Early Deaths                                                                                                                      
    Moribund                                           9           11            9                                                  
    Dead                                               9            8            9                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                32           34           32                                                  
    Dead                                               1                                                                            
  Missing                                              1                                                                            
  Other                                                1                                                                            
  Animals Examined Microscopically                    49           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Gallbladder                                        (44)         (15)         (49)                                                
      Ectasia                                                       1 (7%)                                                          
      Infiltration Cellular, Lymphocyte               15 (34%)      2 (13%)     18 (37%)                                            
      Epithelium, Degeneration                                                   1 (2%)                                             
   Intestine Large, Cecum                             (47)         (16)         (50)                                                
      Serosa, Inflammation, Chronic Active                                       1 (2%)                                             
   Intestine Small, Duodenum                          (46)         (16)         (49)                                                
      Serosa, Inflammation, Chronic Active                                       1 (2%)                                             
   Intestine Small, Ileum                             (46)         (15)         (48)                                                
      Inflammation, Acute                              1 (2%)                                                                       
   Intestine Small, Jejunum                           (46)         (16)         (49)                                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Serosa, Inflammation, Chronic Active                                       1 (2%)                                             
   Liver                                              (49)         (23)         (50)                                                
      Angiectasis                                                                1 (2%)                                             
      Cytomegaly                                       1 (2%)                                                                       
      Developmental Malformation                                    1 (4%)                                                          
      Fatty Change                                     3 (6%)                                                                       
      Focal Cellular Change                            2 (4%)       1 (4%)       2 (4%)                                             
      Hematopoietic Cell Proliferation                 9 (18%)                   7 (14%)                                            
      Infarct                                                                    1 (2%)                                             
      Infiltration Cellular, Lymphocyte               12 (24%)      5 (22%)      7 (14%)                                            
      Necrosis                                         3 (6%)       3 (13%)      4 (8%)                                             
      Vacuolization Cytoplasmic                        1 (2%)                                                                       
      Bile Duct, Cyst                                               1 (4%)       1 (2%)                                             
      Hepatocyte, Hypertrophy                                                    1 (2%)                                             
      Portal, Inflammation, Chronic                    2 (4%)                                                                       
   Mesentery                                          (1)          (5)          (3)                                                 
      Hemorrhage                                                                 1 (33%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic                                                      1 (33%)                                            
      Inflammation, Chronic Active                                               1 (33%)                                            
      Fat, Necrosis                                    1 (100%)     3 (60%)                                                         
   Pancreas                                           (48)         (17)         (50)                                                
      Infiltration Cellular                            1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte                7 (15%)      3 (18%)     10 (20%)                                            
      Acinus, Atrophy                                               2 (12%)      1 (2%)                                             
      Acinus, Hyperplasia                              1 (2%)                                                                       
      Duct, Cyst                                                    1 (6%)       2 (4%)                                             
   Salivary Glands                                    (49)         (16)         (49)                                                
      Infiltration Cellular, Lymphocyte               38 (78%)      9 (56%)     42 (86%)                                            
      Acinus, Atrophy                                  1 (2%)                                                                       
   Stomach, Forestomach                               (48)         (50)         (50)                                                
      Erosion                                                                    1 (2%)                                             
      Hyperkeratosis                                                1 (2%)                                                          
      Hyperplasia, Squamous                            3 (6%)       4 (8%)      19 (38%)                                            
      Infiltration Cellular, Lymphocyte                3 (6%)                    6 (12%)                                            
      Inflammation, Acute                                           3 (6%)       5 (10%)                                            
      Inflammation, Chronic Active                                  1 (2%)       7 (14%)                                            
      Mineralization                                   1 (2%)       2 (4%)       6 (12%)                                            
      Ulcer                                            1 (2%)                    1 (2%)                                             
      Epithelium, Hyperplasia                          1 (2%)                                                                       
      Glandular, Cyst Epithelial Inclusion                          1 (2%)                                                          
   Stomach, Glandular                                 (48)         (50)         (50)                                                
      Erosion                                                                    1 (2%)                                             
      Infiltration Cellular, Lymphocyte               13 (27%)     10 (20%)     22 (44%)                                            
      Inflammation, Acute                              5 (10%)      2 (4%)       2 (4%)                                             
      Inflammation, Chronic Active                     1 (2%)       1 (2%)       1 (2%)                                             
      Mineralization                                   2 (4%)       2 (4%)       9 (18%)                                            
      Mucosa, Dilatation                                            1 (2%)                                                          
      Mucosa, Ectasia                                  4 (8%)       1 (2%)       3 (6%)                                             
      Mucosa, Erosion                                  3 (6%)                                                                       
      Mucosa, Inflammation, Acute                                                1 (2%)                                             
      Mucosa, Mineralization                                        1 (2%)                                                          
      Mucosa, Ulcer                                                              1 (2%)                                             
   Tooth                                              (1)                       (1)                                                 
      Pulp, Inflammation, Chronic                                                1 (100%)                                           
      Pulp, Inflammation, Chronic Active               1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (49)         (16)         (50)                                                
      Infiltration Cellular, Lymphocyte                6 (12%)                   7 (14%)                                            
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Mineralization                                                1 (6%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (49)         (16)         (50)                                                
      Cyst                                             1 (2%)                                                                       
      Hyperplasia                                                                1 (2%)                                             
      Hypertrophy                                      7 (14%)                  11 (22%)                                            
      Spindle Cell, Hyperplasia                       48 (98%)     14 (88%)     46 (92%)                                            
      Spindle Cell, Hyperplasia, Lymphoid                           1 (6%)       1 (2%)                                             
   Adrenal Gland, Medulla                             (49)         (16)         (50)                                                
      Hyperplasia                                      2 (4%)       1 (6%)       2 (4%)                                             
   Islets, Pancreatic                                 (48)         (17)         (50)                                                
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
   Pituitary Gland                                    (47)         (15)         (49)                                                
      Pars Distalis, Cyst                                                        3 (6%)                                             
      Pars Distalis, Hyperplasia                       2 (4%)                    4 (8%)                                             
      Pars Intermedia, Cyst                            1 (2%)                    1 (2%)                                             
   Thyroid Gland                                      (49)         (16)         (49)                                                
      Infiltration Cellular, Lymphocyte                1 (2%)       1 (6%)       4 (8%)                                             
      Ultimobranchial Cyst                             1 (2%)                                                                       
      C-Cell, Hyperplasia                              1 (2%)                    1 (2%)                                             
      Follicle, Ectasia                                1 (2%)       1 (6%)       1 (2%)                                             
      Follicle, Hyperplasia                            4 (8%)                    2 (4%)                                             
      Follicle, Hyperplasia, Cystic                                 1 (6%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (49)         (16)         (50)                                                
      Infiltration Cellular, Lymphocyte               19 (39%)      4 (25%)     25 (50%)                                            
      Serosa, Inflammation, Chronic Active                                       1 (2%)                                             
   Penis                                              (2)                       (3)                                                 
      Inflammation, Acute                              2 (100%)                  2 (67%)                                            
   Preputial Gland                                    (13)         (14)         (11)                                                
      Abscess                                          4 (31%)      5 (36%)      1 (9%)                                             
      Infiltration Cellular, Lymphocyte                             3 (21%)      1 (9%)                                             
      Inflammation, Chronic                            3 (23%)      1 (7%)       4 (36%)                                            
      Inflammation, Chronic Active                     4 (31%)      3 (21%)      5 (45%)                                            
      Duct, Cyst                                       1 (8%)       2 (14%)      1 (9%)                                             
      Duct, Ectasia                                                              1 (9%)                                             
   Prostate                                           (49)         (17)         (50)                                                
      Ectasia                                          1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Seminal Vesicle                                    (49)         (16)         (49)                                                
      Ectasia                                          1 (2%)                    1 (2%)                                             
      Infiltration Cellular, Lymphocyte                2 (4%)                    4 (8%)                                             
      Inflammation, Chronic                                                      3 (6%)                                             
      Serosa, Inflammation, Chronic Active                                       1 (2%)                                             
   Testes                                             (49)         (17)         (50)                                                
      Atrophy                                                                    2 (4%)                                             
      Granuloma Sperm                                                            1 (2%)                                             
      Mineralization                                   1 (2%)       3 (18%)      2 (4%)                                             
      Necrosis                                                      1 (6%)                                                          
      Spermatogenic Arrest                                                       1 (2%)                                             
      Interstitial Cell, Hyperplasia                  16 (33%)                   9 (18%)                                            
      Seminiferous Tubule, Mineralization              1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Blood                                              (1)                                                                           
      Atypia Cellular                                  1 (100%)                                                                     
   Bone Marrow                                        (49)         (17)         (50)                                                
      Angiectasis                                                                1 (2%)                                             
      Hyperplasia, Reticulum Cell                                                1 (2%)                                             
      Myelofibrosis                                    2 (4%)                                                                       
      Myeloid Cell, Hyperplasia                       35 (71%)     12 (71%)     36 (72%)                                            
   Lymph Node                                         (49)         (28)         (50)                                                
      Iliac, Hyperplasia, Lymphoid                                               1 (2%)                                             
      Inguinal, Hyperplasia, Lymphoid                  1 (2%)       3 (11%)                                                         
      Mediastinal, Congestion                                       1 (4%)                                                          
      Mediastinal, Hyperplasia, Lymphoid                            2 (7%)       1 (2%)                                             
      Renal, Hyperplasia, Lymphoid                                               1 (2%)                                             
   Lymph Node, Mandibular                             (49)         (14)         (49)                                                
      Hyperplasia                                                                1 (2%)                                             
      Hyperplasia, Lymphoid                           40 (82%)      4 (29%)     37 (76%)                                            
      Pigmentation                                    10 (20%)      1 (7%)       9 (18%)                                            
   Lymph Node, Mesenteric                             (48)         (28)         (46)                                                
      Angiectasis                                                   2 (7%)       3 (7%)                                             
      Congestion                                      12 (25%)     11 (39%)     10 (22%)                                            
      Hemorrhage                                       1 (2%)       2 (7%)                                                          
      Hyperplasia                                      1 (2%)                                                                       
      Hyperplasia, Lymphoid                           33 (69%)     15 (54%)     35 (76%)                                            
      Inflammation, Acute                              5 (10%)      1 (4%)       3 (7%)                                             
      Inflammation, Chronic                                         1 (4%)                                                          
   Spleen                                             (48)         (21)         (49)                                                
      Angiectasis                                      1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Atrophy                                                                    2 (4%)                                             
      Hematopoietic Cell Proliferation                26 (54%)     13 (62%)     35 (71%)                                            
      Hyperplasia, Glandular                                                     1 (2%)                                             
      Hyperplasia, Lymphoid                            7 (15%)      2 (10%)     10 (20%)                                            
      Pigmentation                                    11 (23%)      2 (10%)      9 (18%)                                            
      Capsule, Inflammation, Chronic Active                                      1 (2%)                                             
   Thymus                                             (47)         (16)         (49)                                                
      Cyst                                             8 (17%)      1 (6%)       9 (18%)                                            
      Hyperplasia, Lymphoid                                         1 (6%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (49)         (42)         (50)                                                
      Alopecia                                                      1 (2%)                                                          
      Angiectasis                                                   1 (2%)                                                          
      Erosion                                          1 (2%)       1 (2%)       1 (2%)                                             
      Fibrosis, Focal                                                            1 (2%)                                             
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Chronic                           18 (37%)     15 (36%)     24 (48%)                                            
      Inflammation, Chronic Active                     4 (8%)       1 (2%)       3 (6%)                                             
      Metaplasia, Osseous                              1 (2%)                                                                       
      Ulcer                                            8 (16%)      6 (14%)      5 (10%)                                            
      Epithelium, Hyperplasia                                                    1 (2%)                                             
      Prepuce, Inflammation, Acute                                               1 (2%)                                             
      Prepuce, Inflammation, Chronic                                1 (2%)                                                          
      Prepuce, Ulcer                                                             1 (2%)                                             
      Subcutaneous Tissue, Abscess                     1 (2%)                                                                       
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                                 (1)          (2)                                                 
      Abscess                                                                    1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (49)         (16)         (50)                                                
      Mineralization                                  40 (82%)      9 (56%)     29 (58%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (49)         (21)         (50)                                                
      Congestion                                       4 (8%)       1 (5%)       4 (8%)                                             
      Hemorrhage                                       5 (10%)      1 (5%)       4 (8%)                                             
      Infiltration Cellular, Lymphocyte               42 (86%)     12 (57%)     43 (86%)                                            
      Infiltration Cellular, Histiocyte                1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                 4 (8%)                    2 (4%)                                             
      Alveolus, Infiltration Cellular, Histiocyte      6 (12%)                   2 (4%)                                             
      Alveolus, Inflammation, Acute                    1 (2%)                                                                       
      Bronchiole, Inflammation, Acute                  4 (8%)                                                                       
      Bronchiole, Inflammation, Chronic Active         1 (2%)                                                                       
      Interstitium, Inflammation, Acute                1 (2%)                                                                       
   Nose                                               (49)         (16)         (49)                                                
      Lumen, Hemorrhage                               24 (49%)      5 (31%)     29 (59%)                                            
      Mucosa, Inflammation, Acute                      1 (2%)                    3 (6%)                                             
      Nasolacrimal Duct, Hemorrhage                    3 (6%)                    1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Acute           1 (2%)       4 (25%)      1 (2%)                                             
      Olfactory Epithelium, Degeneration              26 (53%)      6 (38%)     23 (47%)                                            
      Respiratory Epithelium, Degeneration             1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (2)          (2)                                                 
      Atrophy                                                                    1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (49)         (16)         (50)                                                
      Congestion                                                    1 (6%)                                                          
      Hemorrhage                                                    1 (6%)                                                          
      Infiltration Cellular, Lymphocyte               43 (88%)     12 (75%)     46 (92%)                                            
      Inflammation, Chronic                                         2 (13%)                                                         
      Metaplasia, Osseous                              3 (6%)                    1 (2%)                                             
      Glomerulus, Ectasia                              1 (2%)                                                                       
      Glomerulus, Renal Tubule, Mineralization                      1 (6%)                                                          
      Pelvis, Inflammation, Acute                                                2 (4%)                                             
      Renal Tubule, Casts Protein                      4 (8%)                    4 (8%)                                             
      Renal Tubule, Ectasia                            8 (16%)      1 (6%)       7 (14%)                                            
      Renal Tubule, Mineralization                    12 (24%)      1 (6%)       5 (10%)                                            
      Renal Tubule, Necrosis                          14 (29%)      1 (6%)      23 (46%)                                            
      Renal Tubule, Pigmentation                       1 (2%)                                                                       
      Renal Tubule, Regeneration                      33 (67%)      3 (19%)     36 (72%)                                            
   Urethra                                            (9)          (5)          (15)                                                
      Calculus Micro Observation Only                  9 (100%)     5 (100%)    14 (93%)                                            
      Infiltration Cellular, Lymphocyte                                          1 (7%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05007-05         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           POLYSORBATE 80                                      Date: 09/03/94  
Route: DOSED FEED                                                                                                 Time: 11:32:39  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          UNTREATD     2.5%         5.0%                                                   
                                                    CONTROL                                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
   Urinary Bladder                                    (47)         (16)         (50)                                                
      Ectasia                                                       2 (13%)                                                         
      Infiltration Cellular, Lymphocyte               20 (43%)      4 (25%)     25 (50%)                                            
      Inflammation, Chronic                                                      2 (4%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------